. Receptor-mediated vascular and metabolic actions of endothelin-1 in canine small intestine. Am. J. Physiol. 276 (Gastrointest. Liver Physiol. 39): G1131-G1136, 1999.-The effects of endothelin-1 (ET-1) infusion on blood flow (Q G ) and O 2 uptake (V O 2G ) were examined in the small intestine of anesthetized dogs (n ϭ 10). Arterial and venous flows of a gut segment were isolated, and the segment was perfused at constant pressure. Arterial and gut venous blood samples were taken, gut perfusion pressure and Q G were measured, and O 2 extraction ratio (OER G ) and V O 2G were calculated. ET-1 was infused (0.118 µg · kg Ϫ1 ·min Ϫ1 ia) throughout the experiment. In group 1 (n ϭ 5), ET A receptors were blocked using BQ-123 (0.143 mg · kg Ϫ1 ·min Ϫ1 ia) followed by blockade of ET B receptors with BQ-788 (0.145 mg · kg Ϫ1 ·min Ϫ1 ia). The order of ET A and ET B receptor blockade was reversed in group 2 (n ϭ 5). In group 1, the decrease in Q G observed with ET-1 infusion was partially reversed with BQ-123; no further change occurred after BQ-788 administration. In group 2, addition of BQ-788 to the infusate further decreased Q G , whereas addition of BQ-123 returned Q G to a value not different from that with ET-1 infusion alone. These data indicated that ET-1-induced vasoconstriction in the gut was mediated via ET A receptors and that this constriction was buffered by activation of ET B receptors. V O 2G decreased in proportion to the decrease in Q G with ET-1, decreased further with ET-1 plus ET B receptor blockade (group 2), and increased in proportion to the increases in Q G with ET A receptor blockade (both groups). No changes in OER G occurred during ET A and ET B receptor antagonism in either group. This study is the first to demonstrate that a flowlimited decrease in gut V O 2G occurred with infusion of ET-1 in gut vasculature. An intriguing and novel finding was that, during O 2 limitation, OER G was only 50% of that normally associated with ischemia in this tissue. oxygen uptake; flow limitation; oxygen extraction THE EXPECTED VASCULAR response to infusion of endothelin-1 (ET-1) is a transient dilation that occurs over 30-60 s followed by a prolonged constriction; the maximal constrictor response is normally observed by 15 min but varies somewhat between tissues (19, 28, 33) . The vasoconstrictor action of ET-1 is primarily mediated through activation of ET A receptors (8, 23, 27, 32, 33) and, in some cases, also ET B receptors located on vascular smooth muscle cells (2, 14, 19, 32) . In addition, activation of ET B receptors located on endothelial cells by ET-1 (25) results in the release of the vasodilator substances prostacyclin and/or nitric oxide (NO) (25).
The gut circulation appears to be more susceptible to the vasoconstrictor actions of ET-1 than other peripheral vascular beds. Specifically, the gut vasoconstrictor response to ET-1 is more intense than that observed for iliac flow in anesthetized monkeys (6) , renal and carotid flows in anesthetized cats (21) , and flow in all nongastrointestinal tissues in the anesthetized rat (17) . This sensitivity of the gut vasculature to ET-1 may be of considerable importance in light of the fact that 1) ET-1 levels are elevated in a number of instances, including chronic hypoxia (4, 10) , a variety of surgical interventions (11, 12, 30) , and sepsis (22) , and 2) this tissue has a high resting O 2 uptake (20-25 ml · kg Ϫ1 · min Ϫ1 ) that is normally met by a high blood flow rate (300-500 ml · kg Ϫ1 · min Ϫ1 ) (7, 9, 24, 29) . If blood flow is reduced to the point that gut O 2 delivery falls below critical values (30-40 ml · kg Ϫ1 · min Ϫ1 ), O 2 uptake will be compromised (24) .
To date, no studies have examined the possible metabolic consequences of an ET-1-induced increase in gut vascular resistance and the accompanying reduction in gut blood flow. We have developed an isolated perfused in vivo canine gut loop preparation to examine simultaneously the effects of ET-1 on both blood flow and O 2 uptake in canine small intestine. On the basis of the highly sensitive response of the gut vasculature to ET-1, we hypothesized that ET-1 infusion at concentrations within the moderate range of the dose-response curve (32, 34) would result in a vasoconstriction that would reduce both gut blood flow and gut O 2 uptake.
METHODS
Mongrel dogs (23.9 Ϯ 1.2 kg) were anesthetized with pentobarbital sodium (32 mg/kg iv), paralyzed with succinylcholine chloride (30 mg im and 0.1 mg/min iv), and ventilated to maintain arterial PCO 2 at ϳ30 mmHg. A Swan-Ganz catheter was inserted into the right jugular vein and advanced to the pulmonary artery for thermodilution cardiac output determinations (Baxter, COM-2) and withdrawal of mixed venous blood samples. A catheter was placed in the brachial artery for measurement of mean arterial blood pressure and to obtain arterial blood samples.
A previously described isolated gut loop preparation was modified to control arterial perfusion (9, 24) . Briefly, a midline abdominal incision was made, and a section of small intestine (ileum or jejunum; 26 Ϯ 1 g average wt) subserved by a vascular arcade was exteriorized. The animals were heparinized (1,000 U/kg), and then a two-channel cannula was placed in the vein draining the gut segment. One channel contained an electromagnetic flow probe (Narco) for measurement of venous outflow, whereas the second allowed for in situ zero calibration of the flow probe without occlusion of venous outflow. Venous outflow was returned to the animal via a reservoir attached to a catheter in the right femoral vein. The distal end of a two-channel catheter was placed in the artery
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serving the vascular arcade while the proximal end was inserted into the right femoral artery. This allowed for autoperfusion of the gut segment through one channel or pump perfusion via the second channel in which an in-line peristaltic pump was located. Venous outflow from the gut segment was isolated to the vein draining the segment by tightening ties around the gut tissue at either end of the area served by the vascular arcade. At one end of the segment, an incision was made into the gut tissue, and a temperature probe was inserted into the lumen to monitor temperature of the exteriorized segment. A heat lamp was used to maintain the gut temperature constant during the experiment. Gut perfusion pressure was measured by a pressure transducer attached to a T branch in the arterial cannula just before insertion into the gut arcade artery. Gut perfusion pressure under autoperfused conditions was determined, the gut was pump perfused, and perfusion pressure was maintained within 5% of control values via an electrical feedback system for the remainder of the experiment. To determine if pump perfusion of the gut segment resulted in edema, dry-to-wet weight ratios were determined in the pump-perfused segment and in an autoperfused, nontreated gut segment in one group of animals. The average values for the dry-to-wet weight ratios were not different between the pump-perfused segments (0.29 Ϯ 0.01) and the autoperfused segments (0.32 Ϯ 0.02).
Once surgical and technical preparations were complete, a 30-min period was allowed for cardiovascular and metabolic parameters to stabilize. In preliminary experiments, we found that infusion of 0.1 mg · kg Ϫ1 ·min Ϫ1 ia ET-1 into the canine gut segment vasculature caused an intense vasoconstriction that abolished blood flow. Similarly, Ralevic and Burnstock (26) observed that ET-1 concentrations in excess of 10 Ϫ9 M caused severe vasoconstriction that increased perfusion pressure by 120 mmHg in an in vitro-perfused rat mesentery preparation. In the 10 animals used in the current experiments, initial control measures were obtained and then ET-1 was infused sequentially at two different concentrations (0.060 Ϯ 0.001 and 0.118 Ϯ 0.005 µg · kg Ϫ1 ·min Ϫ1 ia, respectively) into the gut segment; measurements were taken at 20 min of infusion for each concentration (Table 1) . These concentrations of ET-1 were chosen because they evoked physiological increases in gut vascular resistance of 32 and 72%, respectively (Table 1) ; the magnitude of these changes in gut vascular resistance was similar to that reported by others (1, 32, 34) . The protocol was continued with an ongoing infusion of ET-1 at the higher concentration. In group 1, (15) , was then added to the infusate, and measurements were obtained at 30 min postinfusion of BQ-123 ϩ BQ-788. In group 2, the protocol was identical to that followed in group 1 except that BQ-788 was given first, followed by infusion of BQ-123. Others have reported that the concentrations of BQ-123 and BQ-788 must be 1,000-fold greater than the concentration of ET-1 to produce effective antagonism of the vascular effects of this peptide (25, 33) .
At each measurement period, arterial, mixed venous, and gut venous blood samples were taken and whole body and gut perfusion pressure, gut blood flow, and cardiac output were determined. All blood samples were analyzed for PO 2 , PCO 2 , and pH using a Radiometer BMS MKII, and these values were corrected to the temperature of the dog at the time of sampling. O 2 concentration was determined in all samples using an Instrumentation Laboratories 482 Co-Oximeter. The O 2 concentration values were adjusted for the amount of O 2 in solution using the factor 0.03 ml O 2 ·dl Ϫ1 · mmHg (PO 2 ) Ϫ1 . Whole body and gut O 2 uptake were determined using the Fick equation, whereas whole body and gut vascular resistance and O 2 extraction ratio were calculated using standard equations.
All data are reported as means Ϯ SE. Because the treatments were identical for all animals during the control period and ET-1 infusions and the data were not different between the two groups at these times, the data are reported for a total of 10 animals for each of these periods. The effects of ET A and ET B receptor blockade were determined within each group (n ϭ 5), with the blocked values being compared with the control and ET-1 values of the five animals within each specific group using a single repeated measures ANOVA (n ϭ 5). Post hoc multiple comparisons of differences between means were achieved by paired t-test analysis within each group of 5 animals with the critical value for significance (P Ͻ 0.10) adjusted using the Bonferroni correction (P Ͻ 0.017) (31) .
RESULTS
The gut blood flow responses are shown in Fig. 1A . Gut blood flow decreased significantly from the control value in all 10 animals with infusion of ET-1. In group 1, gut blood flow then increased above the value observed during ET-1 infusion alone with the addition of BQ-123 to the infusate but remained significantly less than the initial control values. No further effect on gut blood flow was observed with the addition of BQ-788. In group 2, gut blood flow decreased with the addition of BQ-788 to the infusate; the mean value was significantly less than that observed both during the control period and ET-1 infusion alone. When BQ-123 was added to the infusate, gut blood flow increased significantly above that observed with BQ-788 but remained less than that observed during the control period.
The values for gut vascular resistance are shown in Fig. 1B . Gut vascular resistance increased significantly from the control value with infusion of ET-1. In group 1, after addition of BQ-123 to the infusate, the mean value for gut vascular resistance was not different from that http://ajpgi.physiology.org/ observed during the control period; infusion of BQ-788 had no further effect on gut vascular resistance. In group 2, addition of BQ-788 to the infusate resulted in a significant rise in gut vascular resistance above that observed with ET-1 infusion alone. Addition of BQ-123 to the infusate resulted in a significant decrease in gut vascular resistance to a level not different from that observed during infusion of ET-1 alone. However, this value was significantly greater than that observed during the control period.
The values for gut O 2 uptake are shown in Fig. 2A . Gut O 2 uptake decreased significantly from the control value of 19.2 Ϯ 0.7 to 13.1 Ϯ 1.0 ml · kg Ϫ1 · min Ϫ1 with infusion of ET-1. In group 1, after infusion of BQ-123, the value for gut O 2 uptake was not different from that observed during the control period. Subsequent infusion of BQ-788 resulted in a significant fall in gut O 2 uptake below the control value. In group 2, infusion of BQ-788 resulted in a further decrease in gut O 2 uptake from that observed with ET-1 infusion alone. During infusion of BQ-123, the value for gut O 2 uptake rose significantly to a level that was not different from that observed during ET-1 infusion alone but remained significantly less than the control value.
The values for gut O 2 extraction ratio are shown in Fig. 2B . Gut O 2 extraction increased significantly from a value of 0.34 Ϯ 0.03 in the control period to that of 0.41 Ϯ 0.05 with ET-1 infusion. However, the small increase in O 2 extraction was not sufficient to offset the decrease in gut O 2 uptake (Fig. 2A) . The values for gut O 2 extraction were not different from those observed during the control period when ET A and ET B receptor blockade were induced during ET-1 infusion.
During the last segment of the experiment, the ET A and ET B receptors were blocked in both groups. The values for gut blood flow, resistance, O 2 uptake, and O 2 extraction ratio were not different between the two groups under these conditions.
The values for whole body hemodynamic and metabolic variables and blood gas data are listed in Table 2 . There was no expectation that the local infusion of ET-1, BQ-123, or BQ-788 into the gut segment would have an effect on whole body metabolic or cardiovascu- Fig. 1 . Mean values Ϯ SE for gut blood flow (A) and gut vascular resistance (B). PRU, peripheral resistance units in mmHg · ml Ϫ1 · kg · min. ANT, antagonist. s, Combined data (n ϭ 10) during the control (CON) period and endothelin-1 (ET-1) infusion. n, Data from animals (n ϭ 5) that received BQ-123 followed by BQ-123 ϩ BQ-788. r, Data from animals (n ϭ 5) that received BQ-788 followed by BQ-788 ϩ BQ-123. *Significant difference from control value. †Signifi-cant difference from ET-1 value. ଙ, Significant difference between ANT and ANT ϩ ANT values.
Fig. 2. Mean values Ϯ SE for gut O 2 uptake (A) and gut O 2 extraction ratio (B)
. s, Combined data (n ϭ 10) during the control period and ET-1 infusion. n, Data from animals that received BQ-123 followed by BQ-123 ϩ BQ-788. r, Data from animals that received BQ-788 followed by BQ-788 ϩ BQ-123. * Significant difference from control value. † Significant difference from ET-1 value. ଙ, Significant difference between ANT and ANT ϩ ANT values. http://ajpgi.physiology.org/ lar parameters. This proved to be the case. As normally seen over time during barbiturate anesthesia in dogs, cardiac output decreased and total peripheral resistance increased; no changes in mean arterial pressure or whole body O 2 uptake were observed during the experiment (13) . Arterial PO 2 , PCO 2 , and pH remained stable during the experiment. The values for gut venous PO 2 reflected the O 2 extraction responses of the gut.
DISCUSSION
This is the first study to examine the metabolic consequence of ET-1-induced flow reduction in the small intestine in vivo. As others have reported, we also found that ET-1-induced vasoconstriction was mediated solely through ET A receptors and that ET B receptor activation buffered the magnitude of ET A receptormediated vasoconstriction. The new and important findings in our study were that O 2 uptake fell in proportion to the fall in blood flow during ET-1 administration and that little, if any, compensatory increase in gut O 2 extraction occurred to offset this flow limitation. The latter observation is in striking contrast to the response normally observed in this tissue during local or whole body stagnant hypoxia.
In group 1 as gut vascular resistance increased during ET-1 infusion, gut O 2 uptake and blood flow decreased 32 and 37%, respectively, during ET-1 administration. When gut blood flow returned to control levels during ET A receptor blockade, so did gut O 2 uptake. A similar pattern emerged in group 2; as gut blood flow decreased further (64%) with ET B receptor blockade, gut O 2 uptake also decreased (62%). Subsequent ET A receptor blockade resulted in small but significant increases in both blood flow and gut O 2 uptake, but both values remained significantly less than those observed in the control period. Gut O 2 uptake during infusion of ET-1 in both groups and during infusion of ET-1 and BQ-788 in group 2 appeared to be flow limited. It was surprising that little, if any, compensatory increase in gut O 2 extraction occurred to offset this flow limitation. The average values for gut O 2 extraction ratio ranged from a minimum of 0.34 during control to a maximum value of 0.41 during ET-1 infusion. Previous studies using the same in situ canine gut loop preparation have established that the gut relies heavily on compensatory O 2 extraction responses during periods of reduced O 2 supply (9) such that under conditions of low flow, gut O 2 extraction increased to values ranging from 0.60 to 0.70 (7, 29) . Peak and/or critical values for O 2 extraction in this gut preparation during ischemia have been reported to reach 0.80 (24) . It is not unreasonable to postulate that the failure of the gut to increase O 2 extraction during ET-1 infusion and ET A and ET B receptor blockade was the result of redistribution of gut blood flow away from exchange vessels. Another possibility is that ET-1 administration may have reduced gut O 2 demand through a direct action on cellular metabolism. The latter seems unlikely in light of in vitro studies that have demonstrated that ET-1 causes contraction of guinea pig ileal longitudinal smooth muscle via activation of ET B receptors located on the longitudinal smooth muscle cells (3, 13, 20, 35) . This direct inotropic action of ET-1, if present in situ, would be expected to result in an increase rather than a decrease in gut metabolism and O 2 demand.
We have obtained preliminary data that may provide some insight into the mechanism responsible for the failure of gut O 2 extraction to increase in the face of reduced O 2 delivery following infusion of ET-1. Using intravital videomicroscopy, we observed mesenteric arterial (diameter of ϳ20 µm) microvascular responses during ET-1 infusion (0.1 µg · kg Ϫ1 · min Ϫ1 iv) in anesthetized rats (n ϭ 3). No changes in vessel diameter were observed; however, mean red blood cell velocity and blood flow were significantly reduced at 20 min of ET-1 infusion, and stasis occurred by 25 min of ET-1 infusion (Table 3 ). The mesenteric vessels employed in these experiments were similar in size to third-order arterioles in the submucosal layer. These preliminary findings suggest that ET-1 infusion may result in microvascular plugging independent of changes in vessel diameter, which would significantly reduce the number of capillaries receiving nutritive flow with a resultant decrease in O 2 extraction. Further experiments must be performed to confirm these initial findings.
Our vascular findings that infusion of ET-1 into the gut vasculature at concentrations of ϳ0.06 and 0.12 µg · kg Ϫ1 · min Ϫ1 increased gut vascular resistance 32 and 72%, respectively, were in general agreement with values of 33% (32) and 100% (26) reported by others during infusion of ET-1 at similar concentrations in the perfused rat mesentery. Furthermore, whole body infusion of ET-1 (10 pmol · kg Ϫ1 · min Ϫ1 ) in anesthetized rats increased small intestine vascular resistance fivefold (1). Finally, bolus intravenous administration of ET-1 of 0.1 µg/kg in anesthetized monkeys did not affect mesenteric blood flow, whereas higher concentrations of 0.3, 1.0 and 3.0 µg/kg resulted in decreases in mesenteric blood flow of 20, 40, and 60%, respectively (6).
Our data indicated that ET-1-induced vasoconstriction in the gut vasculature was mediated through ET A receptors. This conclusion was based on the findings that gut vascular resistance returned to levels that were not significantly different from control and gut blood flow also returned to control values when ET A receptor blockade was superimposed during ET-1 infusion. Furthermore, subsequent ET B receptor blockade did not alter gut blood flow or gut vascular resistance. If the constrictor actions of ET-1 had been partially mediated by ET B receptors, then further changes in both gut blood flow and vascular resistance would have been expected with ET B receptor blockade. Our results were consistent with those of Warner et al. (32) , in which the maximal increase in perfusion pressure following administration of ET-1 (10 Ϫ9 M) in the in vitro-perfused rat mesentery bed was reduced ϳ70% by ET A receptor blockade with BQ-123, whereas no further decrease in perfusion pressure was observed with ET A and ET B blockade with PD-142893. In contrast, Allcock et al. (1) were unable to demonstrate any effect of ET A receptor blockade with BQ-123 or ET A and ET B receptor blockade with PD-145065 on ET-1-induced vasoconstriction in the small intestine of anesthetized rats. However, in the latter study, the rats were pretreated with hexamethonium and ET-1 (10 pmol · kg Ϫ1 · min Ϫ1 ) was administered systemically, two factors that may have accounted for the differences between the studies. Our findings and those of Warner et al. (32) clearly demonstrated that ET B receptor blockade caused no further attenuation of ET-1-mediated constriction in the mesenteric vasculature and suggested that ET A receptor activation was the primary mechanism of ET-1-induced vasoconstriction in the mesenteric circulation.
The current study also established that there was a substantial contribution of ET B receptor activation to vascular tone in canine small intestine during ET-1 administration. In group 2, gut vascular resistance, which increased significantly during ET-1 administration, increased an additional 62% with ET B receptor blockade (BQ-788), an effect similar to that reported by Allcock et al. (1) for vascular resistance in the rat small intestine. These data indicate that the vasoconstrictor response of the small intestine to ET-1 is substantially modulated by the simultaneous activation of ET B receptors. The mechanism underlying the magnitude of this buffering capacity is not clear but may be due to the loss of release of dilator substances such as NO or a reduced clearance rate of ET-1 (25) . The latter seems most probable because the dilator response may be of short duration (16) . ET B receptors are the primary method by which ET-1 is cleared from the system (25) , and blockade of these receptors may reduce the clearance rate and therefore enhance the constrictor action of ET-1.
Our findings have demonstrated that the modest increase in vascular resistance that occurred during ET-1 administration resulted in gut ischemia that caused a substantial limitation in gut O 2 uptake. These findings may have direct clinical implications for those situations that promote the release of endogenous ET-1. Plasma ET-1 levels have been shown to double during chronic hypoxia (4, 10), increase 2-to 7-fold during surgeries including small bowel transplantation, abdominal aortic aneurysm resection, and coronary artery bypass grafting (11, 12, 30) , increase 8-fold with chronic peritonitis (5), and increase 15-fold with septic shock (22) . Furthermore, teVelthuis et al. (30) demonstrated that the increase in plasma ET-1 levels during coronary artery bypass surgery was associated with increased circulating endotoxin concentrations. It is possible that the prolonged duration of reduced gut oxygenation as a result of ET-1-induced gut ischemia may contribute to mucosal dysfunction in these conditions.
In conclusion, the findings of the current study demonstrate first that ET-1-induced constriction in the canine small intestine is mediated solely by ET A receptors and second that this constrictor response is substantially modulated by ET B receptor activation. Finally, this study is the first to demonstrate that a flow-limited decrease in gut O 2 uptake occurred with infusion of ET-1 in gut vasculature. An intriguing and novel finding was that, during the period of O 2 limitation, O 2 extraction ratio was only 50% of that normally associated with ischemia in this tissue. 
